Sarawak DAP chief urges state govt to not delay approval of Labour Ordinance amendments

Sarawak DAP chief urges state govt to not delay approval of Labour Ordinance amendments

KUCHING, March 21 — Sarawak DAP chairman Chong Chieng Jen today urged the state government to immediately agree with the proposed amendments to the Sarawak Labour Ordinance (SLO) without further delay. He said the state government should not have insisted on the inclusion of a provision that it must be consulted by the federal government … Read more

Rogue Bersatu MP: We won’t vacate our seats; no guarantee of RoS approval for party rules’ changes

Rogue Bersatu MP: We won’t vacate our seats; no guarantee of RoS approval for party rules’ changes

KUALA LUMPUR, March 2 — An MP today insisted that he would not be stepping down voluntarily as lawmaker for his parliamentary seat, despite Parti Pribumi Bersatu Malaysia’s (Bersatu) decision today to change the political party’s constitution to cause him to lose his seat. National daily Berita Harian today reported Bukit Gantang MP Datuk Syed … Read more

Fusion Fuel Receives Notification of IPCEI Approval from European Commission for 630 MW HEVO-Portugal Project

Fusion Fuel Receives Notification of IPCEI Approval from European Commission for 630 MW HEVO-Portugal Project

SABUGO, Portugal, Feb. 16, 2024 (GLOBE NEWSWIRE) — Fusion Fuel (NASDAQ: HTOO) (the “Company”) is pleased to announce that it has received notification from the European Commission that the Company’s HEVO-Portugal project was among 33 selected for approval under the Important Projects of Common European Interest (“IPCEI”) Hy2Infra program. The €650 million, 630 MW project … Read more

Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers

Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers

BOSTON and ATLANTA, Feb. 07, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease, Parkinson’s-related disorders and other diseases of the Abelson Tyrosine Kinases, today announced preliminary outcomes of the Company’s discussion with the U.S. Food … Read more

CM: Sabah GLC heads to refrain from announcing development projects without state Cabinet’s approval

CM: Sabah GLC heads to refrain from announcing development projects without state Cabinet’s approval

KOTA KINABALU, Jan 10 — The Sabah Cabinet has instructed all heads of state government-linked companies (GLCs) to refrain from announcing or issuing statements on development projects without prior approval of the cabinet. Sabah Chief Minister Datuk Seri Hajiji Noor said all state GLCs are required to refer to their respective ministers or the state … Read more

Sunrise New Energy Receives Approval for Metal Sulfide-Doped Hard Carbon Composite Material Patent, Further Advancing Sodium Battery Material Frontier Technology

Sunrise New Energy Receives Approval for Metal Sulfide-Doped Hard Carbon Composite Material Patent, Further Advancing Sodium Battery Material Frontier Technology

ZIBO, China, Dec. 29, 2023 (GLOBE NEWSWIRE) — Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced that its subsidiary, Sunrise (Guizhou) New Energy Materials Co., Ltd., has received preliminary approval from the National Intellectual Property Office for its invention patent titled “Preparation Method of Metal Sulfide-Doped Hard Carbon … Read more

Court grants approval for Hut 8 to proceed with full mining operations plan in connection to Celsius Network LLC bankruptcy proceedings

Court grants approval for Hut 8 to proceed with full mining operations plan in connection to Celsius Network LLC bankruptcy proceedings

MIAMI, Dec. 29, 2023 (GLOBE NEWSWIRE) — The reorganization plan sponsored by Hut 8 Corp. (Nasdaq | TSX: HUT), (“Hut 8” or the “Company”), one of North America’s largest, most innovative digital asset mining pioneers and high performance computing infrastructure providers, filed in the Celsius Network LLC bankruptcy proceedings was approved by the United States … Read more

Court grants approval for Hut 8 to proceed with full mining operations plan in connection to Celsius Network LLC bankruptcy proceedings

Court grants approval for Hut 8 to proceed with full mining operations plan in connection to Celsius Network LLC bankruptcy proceedings

Miami, Fla, Dec. 29, 2023 (GLOBE NEWSWIRE) — The reorganization plan sponsored by Hut 8 Corp. (Nasdaq | TSX: HUT), (“Hut 8” or the “Company”), one of North America’s largest, most innovative digital asset mining pioneers and high performance computing infrastructure providers, filed in the Celsius Network LLC bankruptcy proceedings was approved by the United … Read more

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION28 December 2023, 07:00 am CET Pending FDA approval, alfapump could become the first active implantable medical device in the US for treating liver ascites Ghent, Belgium – 28 December 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of fluid … Read more

Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

– Innovative design enables five-minute pegfilgrastim delivery time – – Unique, automatic, retractable needle mechanism engineered to maximize safety and comfort for cancer patients receiving pegfilgrastim – REDWOOD CITY, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative … Read more